Alemtuzumab is feasible as substitute for ATG in the conditioning regimen FBM (Fludarabine, BCNU, Melphalan) - a single center study Merle Weniger,Natalie Schub,Thomas Spanberger,Martin Gramatzki,Andreas GuentherBONE MARROW TRANSPLANTATION（2018）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
